Ardelyx (ARDX) Net Income Growth (3y) (2016 - 2026)
Ardelyx (ARDX) Net Income Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,200.25 Bn | 66,199.96 Bn | - | 9.16% |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.75 Bn | 466.96 Bn | 1.35 Bn | 38.43% |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 13.80% |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn | -3.84% |
| 7 | Belite Bio | 62.43 Bn | 62.43 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn | 79.26% |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 47.10% |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | -11.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.99% |
| Dec 31, 2025 | -26.79% |
| Sep 30, 2025 | 65.15% |
| Jun 30, 2025 | 10.86% |
| Mar 31, 2025 | -13.59% |
| Dec 31, 2024 | 28.63% |
| Sep 30, 2024 | 73.52% |
| Jun 30, 2024 | 28.59% |
| Mar 31, 2024 | 7.18% |
| Dec 31, 2023 | 0.09% |
| Sep 30, 2023 | 33.25% |
| Jun 30, 2023 | 11.80% |
| Mar 31, 2023 | -6.17% |
| Dec 31, 2022 | 36.45% |
| Sep 30, 2022 | 0.92% |
| Jun 30, 2022 | -1.89% |
| Mar 31, 2022 | -2.40% |
| Dec 31, 2021 | -9.15% |
| Sep 30, 2021 | -21.79% |
| Jun 30, 2021 | -26.56% |